Magnus Gisslén Selected Research

Central Nervous System Infections (Central Nervous System Infection)

1/2022	Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
12/2021	CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
1/2018	Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
2/2014	Evolving character of chronic central nervous system HIV infection.
2/2013	Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
12/2012	Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy.
12/2010	Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magnus Gisslén Research Topics

Disease

26	HIV Infections (HIV Infection) 07/2022 - 08/2005
26	Infections 01/2022 - 11/2002
23	COVID-19 10/2022 - 01/2020
8	Viremia 11/2022 - 07/2009
8	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 02/2007
7	Central Nervous System Infections (Central Nervous System Infection) 01/2022 - 12/2010
6	Dementia (Dementias) 01/2022 - 01/2014
6	Inflammation (Inflammations) 12/2021 - 12/2009
5	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 12/2009
4	Neuroinflammatory Diseases 01/2020 - 02/2013
4	Leukocytosis (Pleocytosis) 09/2012 - 07/2004
3	Neurologic Manifestations (Neurological Manifestations) 01/2022 - 09/2012
3	Neurocognitive Disorders (Clerambault Syndrome) 01/2019 - 12/2011
2	Opportunistic Infections (Opportunistic Infection) 07/2022 - 12/2009
2	Disease Progression 01/2022 - 06/2013
2	Neoplasms (Cancer) 06/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2007
2	Central Nervous System Diseases (CNS Diseases) 02/2014 - 02/2013
2	Brain Injuries (Brain Injury) 01/2014 - 12/2009
2	AIDS Dementia Complex 12/2009 - 09/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2022
1	Heart Failure 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Stroke (Strokes) 11/2022
1	Critical Illness (Critically Ill) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2021
1	Type 2 Diabetes Mellitus (MODY) 05/2021
1	Virus Diseases (Viral Diseases) 03/2021
1	Hepatitis 01/2021
1	Obesity 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021
1	Overweight 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Lewy Body Disease (Lewy Body Dementia) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 07/2022 - 09/2006
15	RNA (Ribonucleic Acid)IBA 10/2022 - 08/2005
11	Proteins (Proteins, Gene)FDA Link 07/2022 - 12/2009
9	NeopterinIBA 12/2021 - 07/2004
6	Pharmaceutical PreparationsIBA 11/2022 - 02/2012
5	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
5	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2006
4	AntibodiesIBA 01/2022 - 01/2018
4	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019 - 01/2015
4	Amyloid (Amyloid Fibrils)IBA 01/2017 - 12/2009
4	Ritonavir (Norvir)FDA Link 01/2016 - 09/2006
3	Viral RNAIBA 10/2022 - 01/2021
3	enzalutamideIBA 06/2022 - 03/2021
3	Indicators and Reagents (Reagents)IBA 02/2020 - 08/2007
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2006
3	Serum AlbuminIBA 01/2017 - 06/2013
3	Amyloid beta-PeptidesIBA 06/2013 - 12/2009
2	Androgen Antagonists (Antiandrogens)IBA 06/2022 - 01/2022
2	Testosterone (Sustanon)FDA Link 01/2022 - 03/2021
2	AlbuminsIBA 12/2021 - 01/2014
2	Lamivudine (Epivir)FDA Link 01/2021 - 09/2006
2	RacivirIBA 11/2019 - 01/2017
2	HIV AntibodiesIBA 01/2018 - 02/2016
2	Drug CombinationsIBA 01/2018 - 03/2006
2	Lipopolysaccharide ReceptorsIBA 12/2017 - 04/2016
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 01/2006
2	Protons (Proton)IBA 12/2015 - 06/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 06/2011 - 01/2005
1	Oxygen (Dioxygen)IBA 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	remdesivirIBA 10/2022
1	Betamethasone (Celestone)FDA Link 10/2022
1	N-(4-ethoxybenzylidene)-4-butylanilineIBA 06/2022
1	Viral AntigensIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Abiraterone AcetateIBA 01/2022
1	AndrogensIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	bicalutamide (Casodex)FDA LinkGeneric 01/2022
1	WastewaterIBA 02/2021
1	CholesterolIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	NucleoproteinsIBA 01/2021
1	Protein CIBA 01/2021
1	dolutegravirIBA 01/2021
1	CalciumIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	Emtricitabine (Emtriva)FDA Link 11/2019
1	emtricitabine tenofovir alafenamideIBA 11/2019
1	lamivudine drug combination abacavir FDA Link 11/2019
1	FumaratesIBA 11/2019
1	Tenofovir (Viread)FDA Link 11/2019
1	LectinsIBA 01/2019

Therapy/Procedure

18	Therapeutics 11/2022 - 11/2002
9	Highly Active Antiretroviral Therapy (HAART) 06/2021 - 09/2006
5	Art Therapy 11/2022 - 01/2016
3	Critical Care (Surgical Intensive Care) 01/2022 - 05/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 03/2021
1	Long-Term Care 10/2022
1	Tracheotomy 01/2022
1	Condoms (Condom) 01/2021